Study of the Advantages of Using Autologous Platelet-Rich Fibrin Matrix (Obsidian ASG) for the Treatment of Anastomoses in Rectal Operations: A Randomized, Multicenter, Single-Blind Pilot Study
INV. CLINICA PRODUCT SANITARIO COM.
Clinical trial information
- Promoter: VIVOSTAT A/S
- Execution start: 25/05/2022
- End of execution: 30/08/2023
- IP: JORGE RAMOS SANFIEL